NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...

Stevenage, United Kingdom Saturday, January 10, 2026, 14:00 Hrs [IST] ...

In power distribution systems, three-phase transformer configuration directly impacts system reliability and load management.

See some of the top-viewed videos from Trevor Ottmann on job-site tips, tricks, and experiences that we published on ...

QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in ...

For IGBTs, the on-state voltage drop is a critical specification to consider. This drop includes both the diode drop across ...

China dominates and weaponises rare earth supply chain. India’s EV ecosystem can be insulated from it through carefully ...

As the world’s largest technology and automotive companies gathered in Las Vegas this week for the 2026 Consumer Electronics Show (CES), China’s Great Wall Motors (GWM) arrived with a message that ...

Nanjing Delova Biotech Co., Ltd. ("Delova") today announced positive results from two pivotal Phase 3 clinical trials ...

NRG5051 is a first-in-class, orally bioavailable and CNS-penetrant next-generation inhibitor of the mitochondrial permeability transition pore (mPTP), acting through a novel undisclosed ...

JIADING, SHANGHAI, CHINA, January 7, 2026 /EINPresswire.com/ -- Shanghai Trustech Technology Development Co., Ltd. has ...

BENGALURU: A 65-acre tree park will be developed at the state-owned NGEF factory at Baiyappanahalli and the first phase of ...